Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Woodbury

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy - SAPPHIRE Study

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Woodbury

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

BO39633 (IMbrella A), An open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in A Genentech- and/or F.Hoffman-La Roche Ltd. sponsored Atezolizumab Study

  • Details

ClinicalTrials.gov ID: NCT03148418
Diagnosis Type: NSCLC
USOR Number: 17087

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Pages